Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.


Journal

International journal of biological sciences
ISSN: 1449-2288
Titre abrégé: Int J Biol Sci
Pays: Australia
ID NLM: 101235568

Informations de publication

Date de publication:
2019
Historique:
received: 30 03 2019
accepted: 11 07 2019
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 28 4 2020
Statut: epublish

Résumé

Microvesicles are the body's most powerful intercellular communication system and cancer-initiating cell microvesicles (CIC-TEX) reprogram Non-CIC towards fortified malignancy. Claudin7, a CIC-biomarker in gastrointestinal tumors, is recovered in TEX. Recent evidence suggesting individual cells delivering distinct microvesicles became of particular interest for claudin7, which is part of tight junctions (TJ) and glycolipid-enriched membrane domains (GEM), GEM-located claudin7 is palmitoylated. This offered the unique possibility of exploring the contribution of a CIC marker and its origin from distinct membrane domains on CIC-TEX biogenesis and activities. Proteome and miRNA analysis of wild-type, claudin7-knockdown and a rescue with claudin7 harboring a mutated palmitoylation site (mP) of a rat pancreatic and a human colon cancer line uncovered significant, only partly overlapping contributions of palmitoylated and non-palmitoylated claudin7 to TEX composition. Palmitoylated claudin7 facilitates GEM-integrated plasma membrane and associated signaling molecule recruitment; non-palmitoylated claudin7 supports recruitment of trafficking components, proteins engaged in fatty acid metabolism and TJ proteins into TEX. Claudin7mP also assists TEX recovery of selected miRNA. Thus, distinctly located claudin7 affects CIC-TEX composition and TJ-derived cld7 might play a unique role in equipping CIC-TEX with transporters and lipid metabolism-regulating molecules, awareness of distinct TEX populations being crucial facing therapeutic translation.

Identifiants

pubmed: 31592143
doi: 10.7150/ijbs.35347
pii: ijbsv15p2224
pmc: PMC6775303
doi:

Substances chimiques

Claudins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2224-2239

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

J Membr Biol. 2010 Jul;236(2):181-9
pubmed: 20697888
Int J Biochem Cell Biol. 2012 Sep;44(9):1574-84
pubmed: 22728313
Mol Cell Proteomics. 2013 Mar;12(3):587-98
pubmed: 23230278
J Cell Biol. 2018 Jul 2;217(7):2373-2381
pubmed: 29720382
Gut. 2015 Oct;64(10):1529-38
pubmed: 25691495
Int J Cancer. 2013 Jul 15;133(2):416-26
pubmed: 23338841
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6293-300
pubmed: 26578789
Am J Physiol Cell Physiol. 2011 Jan;300(1):C87-96
pubmed: 20926780
Genome Biol. 2009;10(8):235
pubmed: 19706201
Int J Cancer. 2013 Aug 15;133(4):855-66
pubmed: 23390083
Nat Cell Biol. 2009 Sep;11(9):1143-9
pubmed: 19684575
J Proteome Res. 2018 Jan 5;17(1):315-324
pubmed: 29061044
Semin Cell Dev Biol. 2014 Dec;36:177-85
pubmed: 25305579
Ann N Y Acad Sci. 2017 Jun;1397(1):100-109
pubmed: 28636801
Adv Biol Regul. 2015 Jan;57:130-46
pubmed: 25465296
Gastroenterology. 2013 Feb;144(2):369-80
pubmed: 23089202
Semin Cell Dev Biol. 2015 Jun;42:13-21
pubmed: 26003050
Ann N Y Acad Sci. 2012 Jul;1258:9-18
pubmed: 22731710
Semin Cancer Biol. 2012 Oct;22(5-6):396-403
pubmed: 22554795
Oncotarget. 2015 Feb 10;6(4):2046-63
pubmed: 25514462
Am J Cancer Res. 2015 Sep 15;5(10):2944-58
pubmed: 26693051
Int J Mol Sci. 2013 Jul 09;14(7):14240-69
pubmed: 23839094
Nat Rev Cancer. 2009 Jan;9(1):40-55
pubmed: 19078974
Int J Cancer. 2019 Oct 15;145(8):2182-2200
pubmed: 30945750
J Exp Clin Cancer Res. 2015 Apr 02;34:32
pubmed: 25886763
Cell Physiol Biochem. 2007;20(5):495-506
pubmed: 17762176
J Exp Clin Cancer Res. 2018 Apr 27;37(1):92
pubmed: 29703238
Stem Cell Res Ther. 2015 Sep 03;6:153
pubmed: 26334526
Oncotarget. 2016 May 24;7(21):30659-77
pubmed: 27120791
Cell Commun Signal. 2017 Apr 4;15(1):14
pubmed: 28376875
Semin Oncol. 2015 Apr;42 Suppl 1:S3-17
pubmed: 25839664
Commun Integr Biol. 2014 Jan 1;7(1):e28231
pubmed: 24778765
Cell Biol Int. 2018 Nov;42(11):1458-1462
pubmed: 29624789
Int J Mass Spectrom. 2015 Feb 15;378:264-269
pubmed: 25937807
Nat Methods. 2017 Feb 28;14(3):228-232
pubmed: 28245209
Chin J Cancer. 2015 Sep 14;34(12):541-53
pubmed: 26369565
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
Tissue Barriers. 2013 Jul 1;1(3):e25247
pubmed: 24665401
J Exp Clin Cancer Res. 2019 Mar 19;38(1):132
pubmed: 30890157
J Biol Chem. 2008 Mar 28;283(13):8643-53
pubmed: 18211898
J Cell Biochem. 2017 Jan;118(1):66-73
pubmed: 27232975
Cell Commun Signal. 2015 Jun 09;13:29
pubmed: 26054340
Cancer Res. 2016 Jul 15;76(14):4051-7
pubmed: 27216185
Biochim Biophys Acta. 2014 Feb;1838(2):532-45
pubmed: 23899502
J Cell Sci. 2016 Apr 15;129(8):1537-45
pubmed: 27029344
Cancer Res. 1976 Dec;36(12):4562-9
pubmed: 1000501
Mol Cell Proteomics. 2013 Feb;12(2):343-55
pubmed: 23161513
Methods Mol Biol. 2011;762:303-20
pubmed: 21717366
Biochim Biophys Acta. 2014 Jan;1841(1):108-20
pubmed: 24140720
Adv Clin Chem. 2016;74:103-41
pubmed: 27117662
Cancer Sci. 2016 Nov;107(11):1556-1562
pubmed: 27575869
Neoplasia. 2013 Mar;15(3):281-95
pubmed: 23479506
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Front Immunol. 2014 Sep 16;5:442
pubmed: 25278937
Semin Cell Dev Biol. 2014 Dec;36:157-65
pubmed: 25171873
Int J Cancer. 2016 Jan 1;138(1):14-21
pubmed: 25559768
Cell Adh Migr. 2015;9(5):406-15
pubmed: 26091149
Invasion Metastasis. 1983;3(2):109-23
pubmed: 6677621
Ann N Y Acad Sci. 2012 Jun;1257:29-37
pubmed: 22671586
Eur J Cell Biol. 2012 Apr;91(4):226-33
pubmed: 21458101
J Cell Biol. 2016 Jul 4;214(1):5-7
pubmed: 27354377
Cell Rep. 2016 May 3;15(5):978-987
pubmed: 27117408
Curr Opin Cell Biol. 2015 Aug;35:69-77
pubmed: 26001269
Mol Cell Proteomics. 2010 Feb;9(2):197-208
pubmed: 19837982
J Clin Invest. 2016 Apr 1;126(4):1152-62
pubmed: 27035807
Int J Med Sci. 2009;6(2):93-101
pubmed: 19305641
Br J Pharmacol. 2014 Dec;171(24):5462-90
pubmed: 23731188
Semin Cancer Biol. 2014 Oct;28:3-13
pubmed: 24769058
Proteomics. 2013 May;13(10-11):1554-71
pubmed: 23401200
Int J Clin Exp Pathol. 2015 Oct 01;8(10):12225-33
pubmed: 26722407
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Semin Cancer Biol. 2014 Oct;28:39-50
pubmed: 24631836
Biochim Biophys Acta. 2015 Sep;1851(9):1123-33
pubmed: 25900100
Tumour Biol. 2014 May;35(5):3945-51
pubmed: 24420150
Int Rev Cell Mol Biol. 2016;326:175-99
pubmed: 27572129
Gastroenterology. 2012 Feb;142(2):305-15
pubmed: 22044670
Int J Biochem Cell Biol. 2018 Aug;101:94-102
pubmed: 29807095

Auteurs

Daisuke Kyuno (D)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.
Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan.

Nathalie Bauer (N)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.

Martina Schnölzer (M)

Functional Proteome Analysis, DKFZ, Heidelberg, Germany.

Jan Provaznik (J)

Gene Core Center, EMBL, Heidelberg, Germany.

Eduard Ryschich (E)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.

Thilo Hackert (T)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.

Margot Zöller (M)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH